L Voillat
Overview
Explore the profile of L Voillat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Magrangeas F, Avet-Loiseau H, Gouraud W, Lode L, Decaux O, Godmer P, et al.
Leukemia
. 2012 Aug;
27(2):473-81.
PMID: 22874878
Recent studies have provided direct evidence for genetic variegation in subclones for various cancer types. However, little is known about subclonal evolutionary processes according to treatment and subsequent relapse in...
2.
Moreau P, Voillat L, Benboukher L, Mathiot C, Dumontet C, Robillard N, et al.
Leukemia
. 2007 Feb;
21(4):835-6.
PMID: 17268523
No abstract available.
3.
Mannone L, Gardin C, Quarre M, Bernard J, Vassilieff D, Ades L, et al.
Br J Haematol
. 2006 May;
133(5):513-9.
PMID: 16681638
An open-label, phase II non-randomised trial was conducted with darbepoetin (DAR), an erythropoiesis-stimulating factor with prolonged half-life, at a weekly dose of 300 mug subcutaneously in 62 anaemic patients with...
4.
Limat S, Demesmay K, Voillat L, Bernard Y, Deconinck E, Brion A, et al.
Ann Oncol
. 2003 Feb;
14(2):277-81.
PMID: 12562656
Background: To determine the incidence of early cardiotoxicity induced by the CHOP regimen in patients with aggressive non-Hodgkin's lymphoma (NHL) and to identify associated risk factors. Patients And Methods: A...
5.
Cartron G, Voillat L, Desablens B, Le Maignan C, Milpied N, Foussard C, et al.
Leuk Lymphoma
. 2001 Jun;
40(5-6):529-40.
PMID: 11426526
This prospective study was undertaken to evaluate the efficacy and toxicity of combination chemotherapy with alternating cycles of vincristine, doxorubicin and dexamethasone (VAD) and cyclophophamide, doxorubicin, etoposide and prednisone (CHEP)...
6.
Cahn J, Deconinck E, Tiberghien P, Brion A, Racadot E, Deschaseaux M, et al.
Hematol Cell Ther
. 1999 May;
41(2):31-7.
PMID: 10344550
T-cell depletion (TCD) of the bone marrow graft remains the most effective method to prevent severe graft versus host disease after allogeneic bone marrow transplantation. Early studies of HLA-identical sibling...
7.
Moreau P, Milpied N, Voillat L, Colombat P, Mahe B, Rapp M, et al.
Bone Marrow Transplant
. 1998 Jul;
21(12):1193-6.
PMID: 9674850
The aim of the present trial was to investigate the feasibility of high-dose therapy followed by autologous peripheral blood stem cell transplantation (PBSCT) as a component of front-line treatment in...
8.
Toussirot E, Gallinet E, Auge B, Voillat L, Wendling D
Rev Rhum Engl Ed
. 1998 Jul;
65(6):397-405.
PMID: 9670332
Objectives: To report the features of malignancies responsible for a chest wall mass and involving the sternum, the sternocostal and/or sternoclavicular joints, the chondrocostal junction and/or the adjacent soft tissues....
9.
Moreau P, Fleury J, Brice P, Colombat P, Bouabdallah R, Lioure B, et al.
Bone Marrow Transplant
. 1998 May;
21(8):787-93.
PMID: 9603402
This retrospective study was undertaken to evaluate cure rates, toxicity and late effects of early intensive therapy followed by autologous stem cell transplantation (ASCT) in patients with advanced Hodgkin's disease...
10.
Maloisel F, Voillat L, Chenard M, BOEHN A, Lioure B, Oberling F
Ann Oncol
. 1997 Apr;
8(4):405-6.
PMID: 9209674
No abstract available.